Alkermes plc. Payments for Restructuring
Alkermes plc. (ALKS) reported Payments for Restructuring of $97.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2022-04-27
- Alkermes plc. payments for restructuring for the quarter ending 2021-03-31 was $248.00K.
- Alkermes plc. payments for restructuring for the quarter ending 2018-12-31 was $0.00.
- Alkermes plc. payments for restructuring for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- Alkermes plc. payments for restructuring for the quarter ending 2015-06-30 was $500.00K, a 73.68% decline year-over-year.
- Alkermes plc. payments for restructuring for fiscal 2021 was $97.00K.
- Alkermes plc. payments for restructuring for fiscal 2018 was $2.25M.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 9 month as first filed | Payments for Restructuring 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | $97.00K 10-K · filed 2022-02-16 | ||||
| 2021-03-31 | $248.00K 10-Q · filed 2022-04-27 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $2.25M 10-K · filed 2021-02-11 | |||
| 2018-09-30 | $2.25M 10-Q · filed 2019-10-23 | ||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $500.00K derived: sum of 2 quarters · filed 2015-10-29 | $11.80M 10-Q · filed 2015-10-29 | ||
| 2015-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $11.80M 10-Q · filed 2015-07-30 | |||
| 2015-03-31 | $11.30M 10-Q · filed 2015-04-30 | ||||
| 2014-09-30 | $3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | $5.40M derived: sum of 2 quarters · filed 2014-10-29 | $8.60M 10-Q · filed 2014-10-29 | $18.50M derived: sum of 4 quarters · filed 2015-02-24 | |
| 2014-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $5.10M 10-Q · filed 2014-07-31 | $15.00M derived: sum of 3 quarters · filed 2015-02-24 | ||
| 2014-03-31 | $3.20M 10-Q · filed 2014-04-30 | $13.10M derived: sum of 2 quarters · filed 2015-02-24 | |||
| 2013-12-31 | $9.90M derived: 10-K 9 month − 10-Q 6 month · filed 2015-02-24 | $11.10M 10-K · filed 2015-02-24 | $2.30M 10-KT · filed 2014-02-27 | ||
| 2013-09-30 | $1.20M 10-Q · filed 2013-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |